Activation of Shigella Flexneri Type 3 Secretion Requires a Host-induced Conformational Change to the Translocon Pore

Overview

Journal PLoS Pathog

Specialty Microbiology

Date 2019 Nov 15

PMID 31725799

Citations 11

Authors

Brian C Russo

Jeffrey K Duncan

Alexandra L Wiscovitch

Austin C Hachey

Marcia B Goldberg

Affiliations

Soon will be listed here.

Abstract

Type 3 secretion systems (T3SSs) are conserved bacterial nanomachines that inject virulence proteins (effectors) into eukaryotic cells during infection. Due to their ability to inject heterologous proteins into human cells, these systems are being developed as therapeutic delivery devices. The T3SS assembles a translocon pore in the plasma membrane and then docks onto the pore. Docking activates effector secretion through the pore and into the host cytosol. Here, using Shigella flexneri, a model pathogen for the study of type 3 secretion, we determined the molecular mechanisms by which host intermediate filaments trigger docking and enable effector secretion. We show that the interaction of intermediate filaments with the translocon pore protein IpaC changed the pore's conformation in a manner that was required for docking. Intermediate filaments repositioned residues of the Shigella pore protein IpaC that are located on the surface of the pore and in the pore channel. Restricting these conformational changes blocked docking in an intermediate filament-dependent manner. These data demonstrate that a host-induced conformational change to the pore enables T3SS docking and effector secretion, providing new mechanistic insight into the regulation of type 3 secretion.

Citing Articles

Development of the 2a, 3a, 6, and artificial Invaplex (Invaplex) vaccines.

Ross Turbyfill K, Clarkson K, Oaks E, Zurawski D, Vortherms A, Kaminski R mSphere. 2023; 8(4):e0007323.

PMID: 37389412 PMC: 10449495. DOI: 10.1128/msphere.00073-23.

Recent insights into type-3 secretion system injectisome structure and mechanism of human enteric pathogens.

Chen P, Goldberg M Curr Opin Microbiol. 2022; 71:102232.

PMID: 36368294 PMC: 10510281. DOI: 10.1016/j.mib.2022.102232.

PopB-PcrV Interactions Are Essential for Pore Formation in the Pseudomonas aeruginosa Type III Secretion System Translocon.

Kundracik E, Trichka J, Diaz Aponte J, Roistacher A, Rietsch A mBio. 2022; 13(5):e0238122.

PMID: 36154276 PMC: 9600203. DOI: 10.1128/mbio.02381-22.

Type III secretion by Yersinia pseudotuberculosis is reliant upon an authentic N-terminal YscX secretor domain.

Gurung J, Amer A, Chen S, Diepold A, Francis M Mol Microbiol. 2022; 117(4):886-906.

PMID: 35043994 PMC: 9303273. DOI: 10.1111/mmi.14880.

The type 3 secretion system requires actin polymerization to open translocon pores.

Russo B, Duncan-Lowey J, Chen P, Goldberg M PLoS Pathog. 2021; 17(9):e1009932.

PMID: 34499700 PMC: 8454972. DOI: 10.1371/journal.ppat.1009932.

References

Torruellas J, Jackson M, Pennock J, Plano G . The Yersinia pestis type III secretion needle plays a role in the regulation of Yop secretion. Mol Microbiol. 2005; 57(6):1719-33. DOI: 10.1111/j.1365-2958.2005.04790.x. View

Hu B, Morado D, Margolin W, Rohde J, Arizmendi O, Picking W . Visualization of the type III secretion sorting platform of Shigella flexneri. Proc Natl Acad Sci U S A. 2015; 112(4):1047-52. PMC: 4313800. DOI: 10.1073/pnas.1411610112. View

Ide T, Laarmann S, Greune L, Schillers H, Oberleithner H, Schmidt M . Characterization of translocation pores inserted into plasma membranes by type III-secreted Esp proteins of enteropathogenic Escherichia coli. Cell Microbiol. 2001; 3(10):669-79. DOI: 10.1046/j.1462-5822.2001.00146.x. View

Viboud G, Bliska J . Measurement of pore formation by contact-dependent type III protein secretion systems. Methods Enzymol. 2002; 358:345-50. DOI: 10.1016/s0076-6879(02)58100-3. View

Osiecki J, Barker J, Picking W, Serfis A, Berring E, Shah S . IpaC from Shigella and SipC from Salmonella possess similar biochemical properties but are functionally distinct. Mol Microbiol. 2001; 42(2):469-81. DOI: 10.1046/j.1365-2958.2001.02654.x. View

Carlson S, Omary M, Jones B . Identification of cytokeratins as accessory mediators of Salmonella entry into eukaryotic cells. Life Sci. 2002; 70(12):1415-26. DOI: 10.1016/s0024-3205(01)01512-0. View

van der Goot F, Tran van Nhieu G, Allaoui A, Sansonetti P, Lafont F . Rafts can trigger contact-mediated secretion of bacterial effectors via a lipid-based mechanism. J Biol Chem. 2004; 279(46):47792-8. DOI: 10.1074/jbc.M406824200. View

Lafont F, Tran van Nhieu G, Hanada K, Sansonetti P, van der Goot F . Initial steps of Shigella infection depend on the cholesterol/sphingolipid raft-mediated CD44-IpaB interaction. EMBO J. 2002; 21(17):4449-57. PMC: 126195. DOI: 10.1093/emboj/cdf457. View

Radics J, Konigsmaier L, Marlovits T . Structure of a pathogenic type 3 secretion system in action. Nat Struct Mol Biol. 2013; 21(1):82-7. DOI: 10.1038/nsmb.2722. View

10.

Enninga J, Mounier J, Sansonetti P, Tran van Nhieu G . Secretion of type III effectors into host cells in real time. Nat Methods. 2005; 2(12):959-65. DOI: 10.1038/nmeth804. View

11.

Garza-Mayers A, Miller K, Russo B, Nagda D, Goldberg M . Shigella flexneri regulation of ARF6 activation during bacterial entry via an IpgD-mediated positive feedback loop. mBio. 2015; 6(2):e02584. PMC: 4358011. DOI: 10.1128/mBio.02584-14. View

12.

Adams W, Morgan J, Kwuan L, Auerbuch V . Yersinia pseudotuberculosis YopD mutants that genetically separate effector protein translocation from host membrane disruption. Mol Microbiol. 2015; 96(4):764-78. DOI: 10.1111/mmi.12970. View

13.

Kenjale R, Wilson J, Zenk S, Saurya S, Picking W, Picking W . The needle component of the type III secreton of Shigella regulates the activity of the secretion apparatus. J Biol Chem. 2005; 280(52):42929-37. DOI: 10.1074/jbc.M508377200. View

14.

Hu B, Lara-Tejero M, Kong Q, Galan J, Liu J . In Situ Molecular Architecture of the Salmonella Type III Secretion Machine. Cell. 2017; 168(6):1065-1074.e10. PMC: 5393631. DOI: 10.1016/j.cell.2017.02.022. View

15.

Mounier J, Popoff M, Enninga J, Frame M, Sansonetti P, Tran van Nhieu G . The IpaC carboxyterminal effector domain mediates Src-dependent actin polymerization during Shigella invasion of epithelial cells. PLoS Pathog. 2009; 5(1):e1000271. PMC: 2621354. DOI: 10.1371/journal.ppat.1000271. View

16.

Du J, Reeves A, Klein J, Twedt D, Knodler L, Lesser C . The type III secretion system apparatus determines the intracellular niche of bacterial pathogens. Proc Natl Acad Sci U S A. 2016; 113(17):4794-9. PMC: 4855615. DOI: 10.1073/pnas.1520699113. View

17.

Martinez-Argudo I, Blocker A . The Shigella T3SS needle transmits a signal for MxiC release, which controls secretion of effectors. Mol Microbiol. 2010; 78(6):1365-78. PMC: 3020320. DOI: 10.1111/j.1365-2958.2010.07413.x. View

18.

Nans A, Kudryashev M, Saibil H, Hayward R . Structure of a bacterial type III secretion system in contact with a host membrane in situ. Nat Commun. 2015; 6:10114. PMC: 4682100. DOI: 10.1038/ncomms10114. View

19.

Yu X, McGourty K, Liu M, Unsworth K, Holden D . pH sensing by intracellular Salmonella induces effector translocation. Science. 2010; 328(5981):1040-3. PMC: 6485629. DOI: 10.1126/science.1189000. View

20.

Veenendaal A, Hodgkinson J, Schwarzer L, Stabat D, Zenk S, Blocker A . The type III secretion system needle tip complex mediates host cell sensing and translocon insertion. Mol Microbiol. 2007; 63(6):1719-30. DOI: 10.1111/j.1365-2958.2007.05620.x. View